Atara Biotherapeutics (ATRA) Inventory (2022 - 2024)
Atara Biotherapeutics' (ATRA) quarterly Inventory came in at $10.7 million in Q4 2024, up 9.78% YoY from $9.7 million in Q1 2024, and down 23.78% on a QoQ basis from $14.0 million in Q3 2024.
Atara Biotherapeutics (ATRA) Inventory (2022 - 2024) Analysis & Trends
Atara Biotherapeutics (ATRA) has 3 years of Inventory data on file, last reported at $10.7 million in Q4 2024.
- Quarterly Inventory rose 9.78% year-over-year to $10.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $10.7 million (up 9.78% YoY) and the FY2024 annual result came in at $10.7 million, up 9.78% from the prior year.
- Inventory retreated to $10.7 million in Q4 2024, from $14.0 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $18.7 million in Q2 2024 to a low of $1.6 million in Q4 2022.
- A 3-year average of $10.1 million and a median of $9.7 million in 2023 frame the typical range for Inventory.
- Annual changes were most pronounced in 2023 — Inventory soared 511.98% — and 2024, when it rose 9.78%.
- Tracing ATRA's Inventory over 3 years: stood at $1.6 million in 2022, then soared by 511.98% to $9.7 million in 2023, then gained by 9.78% to $10.7 million in 2024.
- The last three Inventory figures came in at $10.7 million (Q4 2024), $14.0 million (Q3 2024), and $18.7 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - | - |
| 10 | Atara Biotherapeutics | 146.12 Mn | 129.57 Mn | 439,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 10.66 Mn |
| Sep 30, 2024 | 13.98 Mn |
| Jun 30, 2024 | 18.75 Mn |
| Mar 31, 2024 | 16.08 Mn |
| Dec 31, 2023 | 9.71 Mn |
| Sep 30, 2023 | 6.59 Mn |
| Jun 30, 2023 | 7.86 Mn |
| Mar 31, 2023 | 5.34 Mn |
| Dec 31, 2022 | 1.59 Mn |